Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  1993-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/gcc.2870080205PMID 7504522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trisomy 7 in nonneoplastic cells

  1993cited by this paper
• PCR-based genetic analysis of DNA from autopsied prostate tissue.

  1993cited by this paper
• Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis.

  1993cited by this paper
• Linkage mapping of human chromosome 10 microsatellite polymorphisms.

  1992cited by this paper
• Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability.

  1992cited by this paper
• Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH).

  1992cited by this paper
• Cytogenetic analysis of 57 primary prostatic adenocarcinomas

  1992cited by this paper
• An Approach to Definition of Genetic Alterations in Prostate Cancer

  1992cited by this paper
• Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma

  1991cited by this paper
• Allelic loss of chromosomes 16q and 10q in human prostate cancer.

  1990cited by this paper
• Three polymorphisms at the D17S29 locus.

  1990cited by this paper
• Dinucleotide repeat polymorphisms at the D7S435 and D7S440 loci

  1990cited by this paper
• Tetranucleotide repeat polymorphism in the LPL gene.

  1990cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• The sex-determining region of the human Y chromosome encodes a finger protein.

  1987cited by this paper
• Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

  1983cited by this paper

• The Genomics of Prostate Cancer: A Historic Perspective.

  2019cites this paper
• Computer aided drug discovery tools and pipelines for molecule targeted inhibition of Topoisomerases I and II in cancer

  2018cites this paper
• Molecular Genetics and Cancer Biology

  2012cites this paper
• Identification of numerical chromosomal changes detected by interphase fluorescence in situ hybridization in high-grade prostate intraepithelial neoplasia as a predictor of carcinoma.

  2009cites this paper
• Review Prostate Cancer Progression Implications of Histopathology

  2007cites this paper
• The role of human papillomavirus infection in prostate cancer.

  2007cites this paper
• Cytogenetics of Prostatic Adenocarcinoma and Precursor Lesions : Analysis of 25 Radical Prostatectomies and I 7 Adjacent

  2006cites this paper
• INTERPHASE CYTOGENETIC ANALYSIS OF erbB2 AND topoIIa CHROMOSOME 17 IN DUCTAL CARCINOMA IN SITU CO-AMPLIFICATION IN INVASIVE BREAST CANCER AND POLYSOMY 01;

  2006cites this paper
• Allelic imbalance and biochemical outcome after radical prostatectomy

  2006cites this paper
• Molecular genetic predictors of prostate cancer progression after radical prostatectomy.

  2006cites this paper
• Concordant copy number and transcriptional activity of genes mapping to derivative chromosomes 8 during cellular immortalization in vitro

  2006cites this paper
• Defining aggressive prostate cancer using a 12-gene model.

  2006cites this paper
• The effectiveness of imaging modalities in clinical staging of localized prostatic carcinoma

  2006cites this paper
• Chromosomal changes in prostate cancer: A fluorescence in situ hybridization study

  2005cites this paper
• Molecular changes in prostatic cancer.

  2005cites this paper
• Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy.

  2004cites this paper
• Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer

  2004cites this paper
• Review of allelic loss and gain in prostate cancer

  2004cites this paper
• Detection of chromosomal aberrations in prostate cancer by fluorescence in situ hybridization (FISH).

  2003cites this paper
• KAI1/CD82 protein expression in primary prostate cancer and in BPH associated with cancer.

  2002cites this paper
• Loss of p53 and c-myc Overrepresentation in Stage T2-3N1-3M0 Prostate Cancer are Potential Markers for Cancer Progression

  2002cites this paper
• Evaluation of Numeric Alterations of Chromosomes 1 and 17 by In Situ Hybridization in Invasive Breast Carcinoma With Clinicopathologic Parameters

  2002cites this paper
• Localized prostate cancer.

  2002cites this paper
• Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers

  2001cites this paper
• Determination of Gene and Chromosome Dosage in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma by Molecular Cytogenetic Techniques

  2001cites this paper
• Fluorescence In Situ Hybridization (FISH) to Metaphase and Interphase Chromosomes.

  2001cites this paper
• Renal Cancer: Methods and Protocols

  2001cites this paper
• Chemoprevention in prostate cancer.

  2001cites this paper
• Quantitation of FISH Signals in Archival Tumors.

  2001cites this paper
• Alteration of X and Y chromosomes in human esophageal squamous cell carcinoma.

  2001cites this paper
• Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS.

  2000cites this paper
• Molecular genetics of prostate cancer.

  2000cites this paper
• Cellular and Molecular Pathology of Prostate Cancer Precursors

  2000cites this paper
• 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer.

  2000cites this paper
• Y chromosome enumeration in touch preparations from 42 prostate tumors by interphase fluorescence in situ hybridization analysis.

  1999cites this paper
• Surrogate Endpoint Biomarkers for Clinical Trials of Prostate Cancer Chemoprevention

  1999cites this paper
• Chromosomal basis of adenocarcinoma of the prostate.

  1999cites this paper
• Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage

  1999cites this paper
• Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer.

  1999cites this paper
• Chapter 5 Molecular biology of prostate cancer: Tumor Suppressor Genes

  1999cites this paper
• Assessing genetic markers of tumour progression in the context of intratumour heterogeneity.

  1998cites this paper
• Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: Identification of a potential tumor suppressor gene site

  1998cites this paper
• Determination of gene and chromosome dosage in prostatic intraepithelial neoplasia and carcinoma.

  1998cites this paper
• Independent origin of multiple foci of prostatic intraepithelial neoplasia

  1998cites this paper
• Precancer of the prostate.

  1998cites this paper
• Numeric Alterations in Chromosomes 7 and 8 Detected by Fluorescent in situ Hybridization Correlate with High-Grade Localized Prostate Cancer

  1998cites this paper
• c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia.

  1998cites this paper
• The impact of prostate-specific antigen, its density and the Gleason score in the prediction of extracapsular disease in prostate carcinoma.

  1997cites this paper
• Cytogenetic studies in prostate cancer: are we making progress?

  1997cites this paper
• Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.

  1997cites this paper
• Human Cytogenetic Cancer Markers

  1997influential citation
• Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

  1997cites this paper
• Current applications of molecular cytogenetic technologies.

  1997cites this paper
• The genetic analysis of prostate carcinoma.

  1997cites this paper
• Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.

  1997cites this paper
• Genetic basis and clonal evolution of human prostate cancer.

  1996cites this paper
• Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.

  1996cites this paper
• Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue.

  1996cites this paper
• Cytogenetic abnormalities are frequent in uncultured prostate cancer cells.

  1996cites this paper
• Correlation of Transrectal Ultrasonography and Core Biopsies with Pathology Results in Radical Prostatectomy Specimens

  1996cites this paper
• Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.

  1996cites this paper
• Molecular biology of prostatic intraepithelial neoplasia

  1996cites this paper
• Breast Cancer Cytogenetics: Clues to Genetic Complexity of the Disease

  1996cites this paper
• Selection toward diploid cells in prostatic carcinoma derived cell cultures

  1996cites this paper
• Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

  1996cites this paper
• Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization.

  1996cites this paper
• Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.

  1996cites this paper
• Tumor Suppressor Genes and Oncogenes in Human Prostate Cancer

  1996cites this paper
• Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers.

  1996cites this paper
• Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression.

  1996cites this paper
• Morphometric applications in anatomic pathology.

  1996cites this paper
• Chromosome Abnormalities in Adenocarcinoma of the Prostate

  1996cites this paper
• Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.

  1995cites this paper
• Organ culture of benign, aging, and hyperplastic human prostate

  1995cites this paper
• Pcr in clinical diagnosis

  1995cites this paper
• Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.

  1995cites this paper
• In vivo amplification of the androgen receptor gene and progression of human prostate cancer

  1995cites this paper
• Loss of Chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers

  1995cites this paper
• Genetic probes in cytology: Principles and applications

  1995cites this paper
• Molecular biology of prostate cancer progression.

  1995cites this paper
• Interphase cytogenetic analysis of erbB2 and topollα co‐amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ

  1995cites this paper
• Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.

  1995cites this paper
• Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias

  1995cites this paper
• Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.

  1995cites this paper
• CYTOGENETIC ANALYSIS OF PROSTATE CARCINOMA BY FLUORESCENCE IN SITU HYBRIDIZATION

  1995cites this paper
• Pre‐neoplastic lesions of the prostate

  1995cites this paper
• Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.

  1995cites this paper
• Molecular genetics and chromosomal alterations in prostate cancer

  1995cites this paper
• Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.

  1995cites this paper
• Molecular biology of prostate cancer.

  1994cites this paper
• Molecular biologic aspects of human prostatic carcinoma.

  1994cites this paper
• Tumor suppressor genes in prostatic oncogenesis.

  1994cites this paper
• Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.

  1994cites this paper
• Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.

  1994cites this paper
• Allelic loss in locally metastatic, multisampled prostate cancer.

  1994cites this paper
• Chromosomal aneuploidy in proliferative breast disease.

  1994cites this paper
• Current and proposed biologic markers in prostate cancer: 1994.

  1994cites this paper
• P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.

  1994cites this paper
• Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.

  1994cites this paper
• DNA aneuploidy in prostatic adenocarcinoma: a frequent event as shown by fluorescence in situ DNA hybridization.

  1994cites this paper